Bryan Stuart

Bryan Stuart

Former President and Chief Executive OfficeratFulcrum Therapeutics· In proxies 2022–2023

Pay in FY2023-53% from the year before · Fulcrum Therapeutics stock -7.3% the same year

Bryan Stuart was paid $1.9M in FY2023 (Dec), down 53%. Fulcrum Therapeutics stock fell 7.3% that year.

Pay$100 in the stock at the end of FY21 → $38
Pay is from the Summary Compensation Table of each Fulcrum Therapeutics proxy. The stock line is the value of $100 put in the stock at the start, from the price change of each fiscal year. Dividends are not in it.

Experience

  1. Fulcrum TherapeuticsPublic company · 4 yr
    • Former President and Chief Executive Officer2022 – Present · 4 yrStock in role -79%

Roles come from the proxy statements of each company.

Activity

For the press:Download CSVDownload PNGHow to use our data

Two people shown as one, or a wrong number?